Host gene expression analysis in Sri Lankan melioidosis patients

Shivankari Krishnananthasivam1, Nimanthi Jayathilaka2, Harindra Darshana Sathkumara1

  • 1Genetech Research Institute, Colombo, Sri Lanka.

Abstract

Insights

Gene expression analysis reveals distinct immune and epigenetic profiles in melioidosis patients, differentiating them from other sepsis cases. These findings highlight potential biomarkers for diagnosing melioidosis and guiding therapeutic interventions.

Area of Science:

  • Infectious Diseases
  • Genomics
  • Immunology

Background:

  • Melioidosis, a severe infectious disease caused by Burkholderia pseudomallei, is prevalent in Southeast Asia and Northern Australia.
  • Understanding host gene expression in melioidosis is vital for elucidating disease mechanisms and severity.
  • This study aimed to compare host gene expression in melioidosis patients with healthy individuals and other sepsis cases.

Purpose of the Study:

  • To analyze gene expression profiles of human host factors in melioidosis patients.
  • To identify correlations between gene expression and disease biomarkers.
  • To differentiate melioidosis from other sepsis infections based on host transcription profiles.

Main Methods:

  • The study included 30 melioidosis patients, 10 healthy controls, and 10 sepsis patients with other causes.
  • Total RNA was extracted from peripheral blood mononuclear cells (PBMCs).
  • Gene expression of 25 targets (19 immune, 6 epigenetic) was analyzed using real-time quantitative PCR (RT-qPCR).

Main Results:

  • Downregulation of inflammatory genes (TLR4, HMGB1) and epigenetic regulators (DNMT3B, HDAC1, HDAC2) was observed in melioidosis patients compared to other sepsis cases.
  • Upregulation of the anti-inflammatory gene IL4 and downregulation of IL8 in septicaemic melioidosis were noted.
  • Consistent downregulation of HMGB1, MICB, PSMB8, PSMB2, PSME2, HDAC1, HDAC2, and DNMT3B occurred in melioidosis, independent of comorbidities.

Conclusions:

  • Differential expression of immune response genes and epigenetic regulators distinguishes melioidosis from other sepsis types.
  • These genes show potential as diagnostic biomarkers for melioidosis.
  • Identifying these gene expression patterns may aid in developing targeted therapeutic interventions for melioidosis.

Related Concept Videos